tiprankstipranks
Tango Therapeutics announces update on PRMT5 program
PremiumThe FlyTango Therapeutics announces update on PRMT5 program
16d ago
Short Report: Archer Aviation shorts at seven-week high
Premium
The Fly
Short Report: Archer Aviation shorts at seven-week high
19d ago
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
3M ago
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
PremiumThe FlyTango Therapeutics price target lowered to $14 from $16 at Guggenheim
6M ago
Tango Therapeutics price target lowered to $13 from $18 at Barclays
Premium
The Fly
Tango Therapeutics price target lowered to $13 from $18 at Barclays
6M ago
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
Premium
The Fly
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
6M ago
Tango Therapeutics price target raised to $17 from $16 at H.C. Wainwright
PremiumThe FlyTango Therapeutics price target raised to $17 from $16 at H.C. Wainwright
8M ago
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
Premium
Company Announcements
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
8M ago
Tango Therapeutics reports Q4 EPS (32c), consensus (28c)
Premium
The Fly
Tango Therapeutics reports Q4 EPS (32c), consensus (28c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100